
Sign up to save your podcasts
Or


In this episode, we’re talking money.
The guests in this discussion recognize that the economic climate has been different (and more chaotic) in last three to four months, but expect a steady but slow improvement as we move into the new year.
This episode reviews 2024’s investment landscape and the policies influencing investment going into 2025.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital
By BioSpace4.9
1313 ratings
In this episode, we’re talking money.
The guests in this discussion recognize that the economic climate has been different (and more chaotic) in last three to four months, but expect a steady but slow improvement as we move into the new year.
This episode reviews 2024’s investment landscape and the policies influencing investment going into 2025.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital

90,994 Listeners

30,666 Listeners

43,528 Listeners

8,776 Listeners

970 Listeners

4,345 Listeners

1,170 Listeners

1,967 Listeners

56,508 Listeners

9,532 Listeners

337 Listeners

6,089 Listeners

6,564 Listeners

34 Listeners

23 Listeners